Background and Aim Obsessive-Compulsive Disorder (OCD) is the fourth most common psychiatric disorder. It consists of symptoms, including intrusive thoughts, rituals, behaviors, preoccupations, and compulsions. This study aimed to evaluate the effectiveness of attention bias modification and selective serotonin reuptake inhibitors in reducing the symptoms of OCD. Methods and Materials study population comprised patients with OCD referring to the outpatient clinic of Amir Kabir Hospital in Arak City, Iran. Of them, 80 patients were randomly assigned to the two groups. The first group received the selective serotonin reuptake inhibitors, and the other group received the treatment modality to determine the effectiveness of the Yale-Brown OCD scale and dot-probe task tests. Ethical Considerations The Research Ethics Committee of Arak University of Medical Sciences approved this study (Research Ethics Code: IR.ARAKMU.REC.1396.284). Results Treatment of attention bias modification in comparison with selective serotonin reuptake inhibitors did not show a significant difference in the reduction of attention bias (P=0.377). Also, a significant difference between the two groups in reducing the symptoms of OCD (P=0.007), indicates that selective serotonin reuptake inhibitors are more effective in diminishing the symptoms of OCD. Besides the attention bias modification decreased the symptoms of OCD, but these results were not significant (P=0.228) Conclusion Attention bias modification is a significant improvement in reducing attention bias and can be used with other interventions. However, it appears that the reduction in the severity of OCD symptoms, as against this intervention, continues to be the preferred treatment for pharmacotherapy.
Introduction
bsessive-Compulsive Disorder (OCD) manifests in a variety of symptoms, including intrusive thoughts, compulsive habits, and mental acts. Obsessive and compulsive behaviors can cause severe discomfort for O the patient and disrupt the normal process of life, work performance, routine social activity, or personal relationships. Medication and cognitive-behavioral therapies are used to treat this disorder, which can dramatically improve 20%-30% of these disorders [1] . One of the methods that may promote the treatment of this disorder is Attentional Bias Modification (ABM) [2, 3] . In this study, we aimed to evaluate and compare the effectiveness of ABM and Selec-tive Serotonin Reuptake Inhibitors (SSRIs) in reducing the symptoms of OCD.
Materials and Methods
This is a clinical trial with a pre-test-post-test design conducted on 80 patients with OCD (diagnosed by a psychiatrist) referred to Amirkabir Hospital in Arak City, Iran. The severity of their OCD was assessed by the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS). Then, they were randomly divided into two groups of 40 people; the first group received standard drug therapy with specific SSRIs (according to the drug reference books), and the second group received ABM treatment in 10 sessions, one session per week each for 30 min. At the end of intervention, the two groups were compared in terms of the efficacy of two treatment methods based on the dependent variables.
For ABM treatment, the researcher first prepared images displaying the common obsessive-compulsive patterns and then evaluated their validity and reliability. Then, for each pattern, 30 images with the highest scores were selected to correct the attentional bias of participants. They completed the Y-BOCS and dot-probe paradigm test after the intervention. The collected data were analyzed in SPSS V. 23 at a significance level of 0.05. Table 1 presents the prevalence of obsessive-compulsive symptoms in the two groups of drug therapy and ABM. As can be seen, obsession with pollution was the most prevalent symptom in two groups. Table 2 compares the severity of obsessive-compulsive symptoms in the two groups before and after the intervention. The independent t-test results showed no significant difference between the two groups in the mean severity of obsessive-compulsive symptoms (P>0.05). Statistical analysis showed that drug therapy significantly reduced symptoms of OCD compared to the ABM method (P=0.007). Overall, the results of this study showed that ABM treatment could not significantly affect OCD compared to drug therapy. Drug therapy was able to reduce the symptoms of OCD more than ABM. The ABM could significantly reduce the attentional bias of patients, while drug therapy could not reduce it in patients. Attentional bias can be the result of an initial risk or threat assessment that, in turn, can trigger harmful cognitive, physiological, and behavioral responses, even though the risk is mild or obscure. Research shows that anxious people pay more attention to threatening information, and these changes have been shown in the amygdala of the brain [6] .
Results

Discussion
In this study, the reduction in attentional bias was significant in the ABM group (P=0.045), but the decrease in the severity of OCD symptoms was not significant in this group (P=0.228). In explaining this result, we can indicate the results of Malgrow's study. He showed that the information that a person would consider depends on their relative importance of the information he assumes in relation to his/ her self-concept. If one can separate individual attention from threatening stimuli and move toward neutral stimuli by using cognitive psychology findings and learning principles, the bias of one's attention may reduce.
The reduction in attentional bias was not significant in the drug therapy group (P=0.328), but the decrease in the severity of OCD symptoms was significant in this group (P<0.001). Symptoms of OCD have a biological basis and may have important psychological implications for the patient. In some studies, the association between serotonin gene alleles and attentional bias has also been stated as a factor for the incidence of OCD [15] . Thus, given the relation of drug therapy with using SSRIs, it may reduce attentional bias. On the whole, the ABM method does not have a significant effect on decreasing symptoms of OCD in the short term but reduces attention bias in patients with OCD. 
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